Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Posted on by sciencefather

Prof Dr. Claudio Bucolo | Pharmacology | Best Researcher Award

Prof Dr. Claudio Bucolo, University of Catania, Italy

Prof. Claudio Bucolo is a distinguished Full Professor of Pharmacology at the University of Catania. With a profound commitment to pharmacological research, particularly in the field of ophthalmology, Prof. Bucolo has garnered international recognition for his groundbreaking work. He has served as a Visiting Scholar at the Eye Research Institute, Oakland University, USA, and has received prestigious awards for his contributions to ocular pharmacology. He has authored over 225 scientific papers, filed 11 international patents, and continues to shape the scientific community with his leadership roles.

profile

Orcid

Strengths for the Award

Prof. Claudio Bucolo stands out as a strong candidate for the Best Researcher Award or Outstanding Scientist Award due to his remarkable achievements in the field of ocular pharmacology and neuropharmacology. He has received multiple prestigious international awards, such as the Dr. Roger Vogel Award and the Gold Fellow Medal for his contributions to ophthalmic disease treatments. With over 225 peer-reviewed publications, 11 international patents, and 8210 citations, his research has made a substantial impact. Additionally, his leadership roles in global conferences (ARVO) and editorial boards demonstrate his academic influence and dedication.

Areas for Improvement

While Prof. Bucolo’s expertise and leadership in ocular pharmacology are well-established, expanding his research focus to other domains of pharmacological research may increase his versatility and influence across broader scientific fields. Collaborating with more interdisciplinary teams could also enhance the global reach of his work. Furthermore, fostering young researchers through mentorship and expanding his role in educational initiatives can further strengthen his candidacy for future honors.

Education 🎓

Prof. Bucolo holds a comprehensive background in pharmacology, with advanced academic training and teaching roles at the University of Catania. His extensive experience as a Visiting Scholar at the Eye Research Institute, Oakland University (USA), has enriched his research perspectives and solidified his expertise in pharmacology applied to ophthalmology.

Experience 🧑‍🏫

Prof. Bucolo has had an illustrious career in academia and pharmacological research, holding key leadership positions at international conferences and organizations. He has served twice as President of the Pharmacology Section for the ARVO Conference Organizing Committee and as a board trustee for the Association for Ocular Pharmacology and Therapeutics. Additionally, he is Deputy Rector for Education in PhD Programs at the University of Catania and Director of the Research Center in Ocular Pharmacology (CERFO).

Research Interest 🔬

Prof. Bucolo’s primary research focuses on ocular pharmacology and neuropharmacology, investigating new drug therapies for ophthalmic diseases. His work contributes to understanding the pharmacodynamics and pharmacokinetics of novel treatments for vision-related disorders. He has made significant strides in neuroprotective strategies and drug delivery systems for ocular health.

Awards 🏆

Prof. Bucolo has received numerous accolades for his contributions to pharmacology and ophthalmology. Notable honors include the “Dr. Roger Vogel Award for Pharmaceutical Research” in 2015, the “Silver Fellow Medal” from the Association for Research in Vision and Ophthalmology (ARVO) in 2014, and the prestigious “Gold Fellow Medal” in 2019 for his outstanding service to the vision community. In 2019, he was also awarded the “Chancellor’s Award Guest” from Louisiana State University for his exceptional contributions to ophthalmic pharmacology.

Publication Top notes 📚

Bucolo C., et al. (2023). “Novel ocular drug delivery systems.” Journal of Ocular Pharmacology and Therapeutics. Cited by 50 articles. Link

Bucolo C., et al. (2022). “Neuroprotective agents in ophthalmology.” Experimental Eye Research. Cited by 40 articles. Link

Bucolo C., et al. (2020). “Advances in pharmacology for retinal diseases.” International Journal of Molecular Sciences. Cited by 65 articles. Link

Conclusion

Prof. Claudio Bucolo is a highly deserving candidate for both the Best Researcher Award and the Outstanding Scientist Award. His groundbreaking contributions to pharmacology, strong publication record, and international recognition solidify his reputation as a leading scientist in ophthalmic research. With a few strategic enhancements in interdisciplinary work and mentorship, his legacy in science could be even more profound.

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Posted on by sciencefather

Dr. Mona Kamal Saadeldin | Pharmacology | Best Researcher Award

Dr. Mona Kamal Saadeldin, Researcher, University of Wisconsin Madison, United States

🌟 Dr. Mona Kamal Saadeldin is a distinguished researcher in pharmacology at the University of Wisconsin-Madison, United States. Her pioneering work in drug development and therapeutic interventions has earned her the prestigious Best Researcher Award 🏆. With a passion for advancing medical science, Dr. Saadeldin’s research focuses on novel treatments to improve patient outcomes 💊. She is celebrated for her innovative contributions and dedication to pharmacological research, making significant strides in the field. Her outstanding achievements and commitment to science continue to inspire and pave the way for future breakthroughs 🔬.

PROFILE 📝

Googlescholar

EDUCATION 🎓

🎓 Dr. Mona Kamal Saadeldin, a distinguished scholar in Pharmaceutical Sciences, earned her Ph.D. in Biochemistry and Molecular Biology from Al-Azhar University, Cairo, in 2017. She holds two M.Sc. degrees: one in Biotechnology from The American University in Cairo (2013) and another in Pharmaceutical Sciences from Al-Azhar University (2013) 🧬. Additionally, she completed a Diploma in Clinical Pharmacy at Ain-Shams University in 2009. Her academic journey began with a B.Sc. in Pharmaceutical Sciences from Ain-Shams University in 2006 🧪. Dr. Saadeldin’s diverse qualifications showcase her dedication to advancing pharmaceutical sciences 🌟.

RESEARCH EXPERIENCE 🔬

🌟 Dr. Mona Kamal Saadeldin is a dedicated researcher in Immuno-oncology at the University of Wisconsin-Madison, focusing on combining Targeted Radionuclide Therapy (TRT) and CAR-T cell therapy for solid tumors. She has led projects at the European Institute of Oncology and the University of Notre Dame, investigating cancer cell resistance and exosome characterization. 🧬💉 In Egypt, Dr. Saadeldin has contributed to diabetes and cancer research, including groundbreaking studies on Sclerostin, Irisin, and genetic variations in tumor suppressor genes. 📚🧪 As an educator, she has supervised and trained students, fostering future scientific innovation. 🌿👩‍🏫

CONFERENCE POSTER PRESENTATIONS 📊

Dr. Mona Kamal Saadeldin has made significant contributions to cancer and disease research, presenting her findings at various prestigious conferences. Her work on NFYC-AS1 lncRNA in cell cycle regulation was highlighted at the EMBO | EMBL Symposium (2021) 🧬. She explored osteocyte markers as diagnostic tools for atherosclerosis in type 2 diabetes at the ENABLE Conference in Copenhagen (2018) 🩺. Additionally, Dr. Saadeldin investigated soluble P-selectin levels as markers for diabetic nephropathy at the ESEO Conference (2018) 💉. Her research on genes in diagnosing urinary bladder and colon cancers was featured at the ENABLE Conference in Barcelona (2017) 🧫.

PROFESSIONAL MEMBERSHIPS 🤝

🎓 Dr. Mona Kamal Saadeldin has distinguished herself in the academic and research community with a diverse range of contributions. She served as a poster presentation judge at the Harper Cancer Research Institute’s 11th Annual Cancer Research event at the University of Notre Dame, IN, USA. 📚 Dr. Saadeldin is an Editorial Board Member for Frontiers in Molecular Biosciences, and an active member of the leadership team at NDnano Grad Student-Postdoc Group. 📝 She is the Main Guest Editor for a Methods Collection in JOVE and Co-guest Editor for a Special Issue in Cancers. Additionally, she reviews for multiple journals, including Frontiers in Pharmacology and Journal of Food Biochemistry. 🌟

AWARDS 🏆

🎓 Dr. Mona Kamal Saadeldin has a distinguished academic background, including postdoctoral fellowships at the University of Milan, Italy, focusing on noncoding-ome roles in cancer research (2021) and pharmacological target identification projects at the European Institute of Oncology (2021, 2018-2020). She received a PhD scholarship from the Ministry of Health, Cairo, Egypt, in 2015 and a Master’s scholarship in 2010. Additionally, Dr. Saadeldin earned a Master fellowship from the American University in Cairo in 2009. 🌟🔬 Her work contributes significantly to oncology and neurological research. 🧬💼

PUBLICATION TOP NOTES 📚

Anti-diabetic effects of fenugreek (Trigonella foenum-graecum): A comparison between oral and intraperitoneal administration – an animal study

Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis

Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study

Effects of Turmeric (Curcuma longa) Extract in streptozocin‐induced diabetic model

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

A critical review of chloroquine and hydroxychloroquine as potential adjuvant agents for treating people with cancer

Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside

Thermal stability of a mercuric reductase from the Red Sea Atlantis II hot brine environment as analyzed by site-directed mutagenesis

Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer

Assist Prof. Dr. Tanya Ralli | Pharmacology | Young Scientist Award

Posted on by sciencefather

Assist Prof. Dr. Tanya Ralli | Pharmacology | Young Scientist Award

Assist Prof. Dr.Tanya Ralli, COER University, Roorkee, India

Assistant Professor Dr. Tanya Ralli, based at COER University in Roorkee, India, is a distinguished figure in pharmacology. Her expertise spans innovative research in pharmaceutical sciences, focusing on groundbreaking advancements. Dr. Ralli’s commitment to academia and her role as a mentor inspire the next generation of scientists. She is renowned for her contributions to pharmacological studies, particularly in areas like drug development and therapeutic interventions. Awarded the prestigious Young Scientist Award, Dr. Ralli continues to drive impactful research that shapes the future of pharmacology. 🌟🔬

PROFILE

Scopus

ACADEMIC BACKGROUND

Dr. Tanya Ralli is currently serving as an Assistant Professor at COER University, Roorkee, since January 2024. She completed her Ph.D. in Pharmaceutics from Jamia Hamdard, New Delhi, in December 2023. Her academic journey includes an M.S. in Pharmaceutics from NIPER, S.A.S Nagar, with a remarkable 9.92 CGPA and a Bachelor of Pharmacy from DIPSAR, Delhi. Dr. Ralli has also pursued advanced diplomas in Patent Law from NALSAR, Hyderabad, and Regulatory Affairs from Jamia Hamdard. Her educational foundation started with excellence in Senior and Secondary School from Kulachi Hansraj Model School. 🎓

RESEARCH PROJECT

🎓 Assist. Prof. Dr. Tanya Ralli completed her Ph.D. at Jamia Hamdard under the guidance of Prof. Kanchan Kohli and Prof. Vidhu Aeri. Her research focused on the development of formulations containing bacteria and herbal drugs for the treatment of NAFLD (Non-Alcoholic Fatty Liver Disease). Earlier, she pursued her M.S. (Pharm) project titled “To study the crystallization tendency of ASDs and validate its correlation with Isobaric Fragility and Alpha relaxation stretch parameter,” supervised by Prof. Arvind Kumar Bansal. Dr. Ralli’s academic journey reflects her commitment to pharmaceutical research and innovative healthcare solutions.

AWARDS AND HONOR

🏆 Dr. Tanya Ralli has garnered notable recognition throughout her academic and professional journey. She achieved the prestigious Best E Abstract Award at the NIPER-Hyderabad online conference in 2020, showcasing her research prowess. Her academic excellence was highlighted by receiving a Gold Medal as the University Topper during her M.S. (Pharm.) at NIPER. She was honored by MHRD for being among India’s top 100 students and by the Delhi Pharmacy Council for securing the 2nd position in B.Pharm. Dr. Ralli’s dedication to volunteerism was acknowledged with the Best Volunteer Award at the IPC in 2013. 🌟

PROFESSIONAL SKILLS

🔬 Assist Prof. Dr. Tanya Ralli brings a wealth of technical expertise to her research endeavors. Her skills include operating advanced instruments such as High Performance Liquid Chromatography (HPLC), UV spectrophotometer, and IR spectroscopy. She specializes in isolating herbal compounds using preparative HPLC and High Performance Thin Layer Chromatography (HPTLC), alongside techniques like Differential Scanning Calorimeter (DSC) and Dielectric Spectroscopy (DES). Proficient in MS Office, ChemDraw, and data analysis tools like SPSS and Python, she excels in molecular docking analysis and bioinformatics. Her ability to retrieve data from scientific databases and her aptitude in report drafting underscore her multidisciplinary approach.

KEY ACHIEVEMENTS

Dr. Tanya Ralli is a distinguished academician and researcher, renowned for her achievements in pharmaceutical sciences. She clinched the Best e-Abstract Award at NIPER-Hyderabad’s 2020 online conference and was honored with a Certificate of Distinction at the GO4youth Olympiad by TERI in 2019-2020. Her academic prowess shone through as she secured the University Topper title and a Gold Medal in M.S. (Pharm.). Dr. Ralli’s excellence was recognized nationally when she was felicitated by MHRD for ranking among India’s top 100 students. Her journey also includes accolades from Delhi Pharmacy Council and IPC for her outstanding academic and volunteer contributions. 🏅

WORPSHOPS ATTENDED

Dr. Tanya Ralli is a dedicated academic with a passion for continuous learning and professional development. She has actively participated in several prestigious workshops and conferences to enhance her expertise. Notably, she attended the international workshop on Quality by Design in December 2022, and earlier, engaged in workshops like PUMAS in February 2020 and Bio-Statistical Analysis on SPSS & Research Paper Writing in December 2019. Her training extends to practical skills such as HPLC through sessions by Jamia Hamdard and Shimadzu in September 2019. Dr. Ralli also contributed to the field of phytopharmaceuticals at the IPC’s residential course in 2019. Her commitment to knowledge includes participation in conferences like the 6th International Conference on Cardiovascular Sciences in 2014 and volunteering at the 65th Indian Pharmaceutical Congress in 2013. 🎓

EXPERIENCE

Dr. Tanya Ralli has a diverse academic and professional background. She has contributed significantly to academia, teaching B. Pharm and D. Pharm classes at Jamia Hamdard for 2 years, from 2021 to 2023. Her passion for education extended beyond formal settings, with 6 months of voluntary teaching at the NGO “Umeed: A drop of hope” in 2021. Dr. Ralli enhanced her skills through intensive training in bioinformatics, R programming, Python, and Next Generation Sequencing at Eminent Biosciences. Additionally, she gained expertise in HPLC and HPTLC during a 3-month training at the Indian Pharmacopoeia Commission for her PhD. Her career also includes part-time teaching at ASS Science Foundation and a role as a trainee analyst at WNS Global Services. 📚

Publication Top Notes

Exploring the therapeutic potential of silymarin-based herbal remedy (prebiotic) and probiotic blend in a mouse model of NAFLD: Insights into gut microbiota modulation and liver health

Hypothesizing the Green Synthesis of Tamoxifen Loaded Magnetic Nanoparticles for the Treatment of Breast Cancer

Cannabis sativa in Phytotherapy: Reappraisal of Therapeutic Potential and Regulatory Aspects

BBD Driven Fabrication of Hydroxyapatite Engineered Risedronate Loaded Thiolated Chitosan Nanoparticles and Their In Silico, In Vitro, and Ex Vivo Studies

Investigation of Luliconazole-Loaded Mucoadhesive Electrospun Nanofibers for Anticandidal Activity in the Management of Vaginal Candidiasis

Drug-loaded electrospun nanofiber for Vulvovaginal candidiasis: A systematic literature review

Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement

Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer

Decoding the bidirectional relationship between gut microbiota and COVID-19

Silymarin as a phyto-pharmaceutical: Isolation, simultaneous quantification of four biomarkers and in-silico anti-inflammatory activity